GGTI-2418

N/A

Report date: 2025/03/04 20:00:11
NME

Base Information

Drug NameGGTI-2418
Drug Alias NameGGTI-2418PTX-100PTX-001
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGeranylgeranyl transferase type I inhibitors
TargetsGeranylgeranyl transferase type I
Therapy Area/IndicationsLymphoma, T-Cell, PeripheralLymphoma, T-Cell, CutaneousNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyAustralia +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrescient
China Registration ClassN/A

Develop Information

Active CompaniesPrescient Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsLymphoma, T-Cell, PeripheralLymphoma, T-Cell, Cutaneous
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A